Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 2-amino-4,5-difluorobenzoate is a chemical compound with the molecular formula C9H8F2NO2. It is an ester formed from methyl alcohol and 2-amino-4,5-difluorobenzoic acid. This white crystalline solid is known for its potential use in the synthesis of pharmaceuticals and agrochemicals, with its two fluorine atoms and an amino group on the benzene ring contributing to its versatility and utility in the development of novel drugs and other organic compounds.

207346-42-7

Post Buying Request

207346-42-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

207346-42-7 Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-amino-4,5-difluorobenzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of novel drugs. The presence of fluorine atoms can enhance the pharmacokinetic properties of the resulting compounds, potentially improving their efficacy and safety.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-amino-4,5-difluorobenzoate is utilized as a precursor in the production of agrochemicals. Its unique structure allows for the creation of compounds that can be effective in pest and disease control, taking advantage of the reactive nature of the fluorine atoms and the functional groups present in the molecule.
Used in Organic Synthesis:
Methyl 2-amino-4,5-difluorobenzoate serves as a versatile intermediate in organic synthesis, where its structural features can be exploited to produce a variety of organic compounds. The amino group on the benzene ring is particularly useful for further functionalization, making it a valuable building block for the synthesis of complex organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 207346-42-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,3,4 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 207346-42:
(8*2)+(7*0)+(6*7)+(5*3)+(4*4)+(3*6)+(2*4)+(1*2)=117
117 % 10 = 7
So 207346-42-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H7F2NO2/c1-13-8(12)4-2-5(9)6(10)3-7(4)11/h2-3H,11H2,1H3

207346-42-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H64385)  Methyl 2-amino-4,5-difluorobenzoate, 98%   

  • 207346-42-7

  • 5g

  • 196.0CNY

  • Detail
  • Alfa Aesar

  • (H64385)  Methyl 2-amino-4,5-difluorobenzoate, 98%   

  • 207346-42-7

  • 25g

  • 647.0CNY

  • Detail
  • Alfa Aesar

  • (H64385)  Methyl 2-amino-4,5-difluorobenzoate, 98%   

  • 207346-42-7

  • 100g

  • 2156.0CNY

  • Detail

207346-42-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2-amino-4,5-difluorobenzoate

1.2 Other means of identification

Product number -
Other names 2-amino-4,5-difluoro-benzoic acid,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:207346-42-7 SDS

207346-42-7Relevant academic research and scientific papers

ANTIVIRAL COMPOUNDS

-

Paragraph 0302, (2013/08/28)

The present invention provides new antiviral compounds and pharmacological compositions comprising these new compounds and their use in the prophylaxis, prevention and treatment of viral infections, particularly adenovirus and herpes virus infections.

Synthesis, biological evaluation, and structure-activity relationships of 2-[2-(benzoylamino)benzoylamino]benzoic acid analogues as inhibitors of adenovirus replication

?berg, Christopher T.,Strand, M?rten,Andersson, Emma K.,Edlund, Karin,Tran, Nam Phuong Nguyen,Mei, Ya-Fang,Wadell, G?ran,Elofsson, Mikael

experimental part, p. 3170 - 3181 (2012/06/04)

2-[2-Benzoylamino)benzoylamino]benzoic acid (1) was previously identified as a potent and nontoxic antiadenoviral compound (Antimicrob. Agents Chemother. 2010, 54, 3871). Here, the potency of 1 was improved over three generations of compounds. We found that the ortho, ortho substituent pattern and the presence of the carboxylic acid of 1 are favorable for this class of compounds and that the direction of the amide bonds (as in 1) is obligatory. Some variability in the N-terminal moiety was tolerated, but benzamides appear to be preferred. The substituents on the middle and C-terminal rings were varied, resulting in two potent inhibitors, 35g and 35j, with EC50 = 0.6 μM and low cell toxicity.

NEW ANTIVIRAL COMPOUNDS

-

Page/Page column 52; 58, (2012/01/05)

The present invention provides new antiviral compounds and pharmacological compositions comprising these new compounds and their use in the prophylaxis, prevention and treatment of viral infections, particularly adenovirus and herpes virus infections.

PLATELET ADP RECEPTOR INHIBITORS

-

Page/Page column 33, (2008/06/13)

Compounds are provided which are useful as platelet ADP receptor inhibitors, for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient.

4-Hydroxy-2-quinolones. 90.* Synthesis and antitubercular activity of 4-methyl-2-thiazolylamides of halo-substituted 4-hydroxy-2-oxo-1,2-dihydro-3- quinolinecarboxylic acids

Ukrainets,Sidorenko,Petrushova,Gorokhova

, p. 64 - 69 (2007/10/03)

Several variants were studied for the synthesis of esters of halogen derivatives of 4-hydroxy-2-oxo-1,2-dihydro-3-quinolinecarboxylic acids, whose reaction with 2-amino-4-methylthiazole gives the corresponding hetarylamides. Results are given for a study of the antitubercular activity of these products. 2006 Springer Science+Business Media, Inc.

Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones

-

, (2008/06/13)

The invention provides chemistry libraries containing fused 2,4-pyrimidinediones. The invention also provides methods for the construction of fused 2,4-pyrimidinedione containing libraries. The invention further provides methods for the identification of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 207346-42-7